Clinical Trials Browser

Active not recruiting × Lymphoma, Large-Cell, Anaplastic × Brentuximab Vedotin × Clear all

NCT03113500 2025-11-14

Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With CD30-Positive Peripheral T-cell Lymphoma

Immunoblastic Lymphadenopathy, Lymphoma, T-Cell, Lymphoma, Large-Cell, Anaplastic, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Enteropathy-Associated T-Cell Lymphoma

NCT07013565 2025-10-21

ACCELERATE

Phase 2 Active not recruiting

20 enrolled

Lymphoid

Lymphoma, Large-Cell, Anaplastic